219 related articles for article (PubMed ID: 19920191)
1. In benign Barrett's epithelial cells, acid exposure generates reactive oxygen species that cause DNA double-strand breaks.
Zhang HY; Hormi-Carver K; Zhang X; Spechler SJ; Souza RF
Cancer Res; 2009 Dec; 69(23):9083-9. PubMed ID: 19920191
[TBL] [Abstract][Full Text] [Related]
2. Deoxycholic acid causes DNA damage while inducing apoptotic resistance through NF-κB activation in benign Barrett's epithelial cells.
Huo X; Juergens S; Zhang X; Rezaei D; Yu C; Strauch ED; Wang JY; Cheng E; Meyer F; Wang DH; Zhang Q; Spechler SJ; Souza RF
Am J Physiol Gastrointest Liver Physiol; 2011 Aug; 301(2):G278-86. PubMed ID: 21636532
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide and acid induce double-strand DNA breaks in Barrett's esophagus carcinogenesis via distinct mechanisms.
Clemons NJ; McColl KE; Fitzgerald RC
Gastroenterology; 2007 Oct; 133(4):1198-209. PubMed ID: 17919494
[TBL] [Abstract][Full Text] [Related]
4. In Barrett's esophagus patients and Barrett's cell lines, ursodeoxycholic acid increases antioxidant expression and prevents DNA damage by bile acids.
Peng S; Huo X; Rezaei D; Zhang Q; Zhang X; Yu C; Asanuma K; Cheng E; Pham TH; Wang DH; Chen M; Souza RF; Spechler SJ
Am J Physiol Gastrointest Liver Physiol; 2014 Jul; 307(2):G129-39. PubMed ID: 24852569
[TBL] [Abstract][Full Text] [Related]
5. In Barrett's epithelial cells, weakly acidic bile salt solutions cause oxidative DNA damage with response and repair mediated by p38.
Huo X; Dunbar KB; Zhang X; Zhang Q; Spechler SJ; Souza RF
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G464-G478. PubMed ID: 31984785
[TBL] [Abstract][Full Text] [Related]
6. Differences in activity and phosphorylation of MAPK enzymes in esophageal squamous cells of GERD patients with and without Barrett's esophagus.
Zhang HY; Zhang X; Chen X; Thomas D; Hormi-Carver K; Elder F; Spechler SJ; Souza RF
Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G470-8. PubMed ID: 18617556
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of oxidant production in esophageal squamous cell and Barrett's cell lines.
Feagins LA; Zhang HY; Zhang X; Hormi-Carver K; Thomas T; Terada LS; Spechler SJ; Souza RF
Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G411-7. PubMed ID: 18063706
[TBL] [Abstract][Full Text] [Related]
8. Toll-like Receptor 2 Signalling and the Lysosomal Machinery in Barrett's Esophagus.
Verbeek RE; Siersema PD; Vleggaar FP; Ten Kate FJ; Posthuma G; Souza RF; de Haan J; van Baal JW
J Gastrointestin Liver Dis; 2016 Sep; 25(3):273-82. PubMed ID: 27689189
[TBL] [Abstract][Full Text] [Related]
9. Changes in mitochondrial stability during the progression of the Barrett's esophagus disease sequence.
O'Farrell NJ; Feighery R; Picardo SL; Lynam-Lennon N; Biniecka M; McGarrigle SA; Phelan JJ; MacCarthy F; O'Toole D; Fox EJ; Ravi N; Reynolds JV; O'Sullivan J
BMC Cancer; 2016 Jul; 16():497. PubMed ID: 27431913
[TBL] [Abstract][Full Text] [Related]
10. Role of intracellular calcium and NADPH oxidase NOX5-S in acid-induced DNA damage in Barrett's cells and Barrett's esophageal adenocarcinoma cells.
Li D; Cao W
Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(10):G863-72. PubMed ID: 24699332
[TBL] [Abstract][Full Text] [Related]
11. A novel mechanism of acid and bile acid-induced DNA damage involving Na+/H+ exchanger: implication for Barrett's oesophagus.
Goldman A; Shahidullah M; Goldman D; Khailova L; Watts G; Delamere N; Dvorak K
Gut; 2010 Dec; 59(12):1606-16. PubMed ID: 20876775
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of PARP1 is involved in development of Barrett's esophagus.
Zhang C; Ma T; Luo T; Li A; Gao X; Wang ZG; Li F
World J Gastroenterol; 2018 Mar; 24(9):982-991. PubMed ID: 29531462
[TBL] [Abstract][Full Text] [Related]
13. Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett's metaplasia.
Wang DH; Clemons NJ; Miyashita T; Dupuy AJ; Zhang W; Szczepny A; Corcoran-Schwartz IM; Wilburn DL; Montgomery EA; Wang JS; Jenkins NA; Copeland NA; Harmon JW; Phillips WA; Watkins DN
Gastroenterology; 2010 May; 138(5):1810-22. PubMed ID: 20138038
[TBL] [Abstract][Full Text] [Related]
14. Acid increases MAPK-mediated proliferation in Barrett's esophageal adenocarcinoma cells via intracellular acidification through a Cl-/HCO3- exchanger.
Sarosi GA; Jaiswal K; Herndon E; Lopez-Guzman C; Spechler SJ; Souza RF
Am J Physiol Gastrointest Liver Physiol; 2005 Dec; 289(6):G991-7. PubMed ID: 16081761
[TBL] [Abstract][Full Text] [Related]
15. Glutathione peroxidase 7 protects against oxidative DNA damage in oesophageal cells.
Peng D; Belkhiri A; Hu T; Chaturvedi R; Asim M; Wilson KT; Zaika A; El-Rifai W
Gut; 2012 Sep; 61(9):1250-60. PubMed ID: 22157330
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial STAT3 contributes to transformation of Barrett's epithelial cells that express oncogenic Ras in a p53-independent fashion.
Yu C; Huo X; Agoston AT; Zhang X; Theiss AL; Cheng E; Zhang Q; Zaika A; Pham TH; Wang DH; Lobie PE; Odze RD; Spechler SJ; Souza RF
Am J Physiol Gastrointest Liver Physiol; 2015 Aug; 309(3):G146-61. PubMed ID: 26045618
[TBL] [Abstract][Full Text] [Related]
17. Acid has antiproliferative effects in nonneoplastic Barrett's epithelial cells.
Feagins LA; Zhang HY; Hormi-Carver K; Quinones MH; Thomas D; Zhang X; Terada LS; Spechler SJ; Ramirez RD; Souza RF
Am J Gastroenterol; 2007 Jan; 102(1):10-20. PubMed ID: 17266684
[TBL] [Abstract][Full Text] [Related]
18. Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett's oesophagus.
Dvorak K; Payne CM; Chavarria M; Ramsey L; Dvorakova B; Bernstein H; Holubec H; Sampliner RE; Guy N; Condon A; Bernstein C; Green SB; Prasad A; Garewal HS
Gut; 2007 Jun; 56(6):763-71. PubMed ID: 17145738
[TBL] [Abstract][Full Text] [Related]
19. Unlike esophageal squamous cells, Barrett's epithelial cells resist apoptosis by activating the nuclear factor-kappaB pathway.
Hormi-Carver K; Zhang X; Zhang HY; Whitehead RH; Terada LS; Spechler SJ; Souza RF
Cancer Res; 2009 Jan; 69(2):672-7. PubMed ID: 19147583
[TBL] [Abstract][Full Text] [Related]
20. Differences in ERK activation in squamous mucosa in patients who have gastroesophageal reflux disease with and without Barrett's esophagus.
Souza RF; Shewmake KL; Shen Y; Ramirez RD; Bullock JS; Hladik CL; Lee EL; Terada LS; Spechler SJ
Am J Gastroenterol; 2005 Mar; 100(3):551-9. PubMed ID: 15743351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
